Heart Health: Early Warning Signs Hidden in Your Blood Work

Cardiovascular disease (CVD) remains the leading cause of death in Australia, claiming approximately one life every 12 minutes. Yet here's the sobering reality: for many people, the first symptom of heart disease is the heart attack itself. By the time symptoms appear, atherosclerosis — the buildup of plaque in arterial walls — has typically been progressing silently for decades.

The good news? Your blood carries early warning signals that can identify cardiovascular risk 10–20 years before a clinical event. The challenge is knowing which markers to test and how to interpret them.

ApoB: The Particle That Drives Atherosclerosis

Apolipoprotein B is arguably the single most important blood marker for cardiovascular risk. Every atherogenic lipoprotein particle — LDL, VLDL, IDL, and Lp(a) — carries exactly one ApoB molecule. ApoB therefore represents a direct count of the particles that can penetrate the arterial wall and initiate plaque formation.

A 2019 meta-analysis in JAMA Cardiology confirmed that ApoB is a more accurate predictor of cardiovascular events than LDL-C or non-HDL-C. Optimal ApoB is below 0.7 g/L for primary prevention and below 0.65 g/L for those with existing disease or very high risk.

Lipoprotein(a): The Genetic Time Bomb

Lp(a) is a genetically determined lipoprotein that increases cardiovascular risk independently of other lipid markers. Approximately 20% of the global population has elevated Lp(a) (> 75 nmol/L), but most have never been tested. Unlike LDL-C, Lp(a) levels are 90% genetically determined and largely resistant to lifestyle modification.

Why does it matter? Elevated Lp(a) increases the risk of myocardial infarction by 2–3 fold, stroke by 1.5 fold, and aortic valve stenosis by 2–3 fold. If your Lp(a) is elevated, it changes your entire risk calculation — making aggressive management of modifiable risk factors even more critical.

You only need to test Lp(a) once in your lifetime. If you haven't, request it at your next blood test.

hs-CRP: The Vascular Inflammation Marker

Atherosclerosis is fundamentally an inflammatory disease. High-sensitivity CRP measures systemic inflammation and independently predicts cardiovascular events. The landmark CANTOS trial demonstrated that reducing inflammation (via an IL-1β inhibitor) reduced cardiovascular events by 15% — without changing cholesterol levels. This confirmed that inflammation is a causal pathway, not merely a bystander.

For cardiovascular risk assessment, hs-CRP below 1.0 mg/L is low risk, 1.0–3.0 mg/L is moderate, and above 3.0 mg/L is high. Values above 10 mg/L suggest acute infection and should be retested after resolution.

Homocysteine: The Methylation Marker

Elevated homocysteine (> 10 μmol/L) damages the endothelial lining of blood vessels, promotes clot formation, and is an independent risk factor for cardiovascular disease and stroke. It's particularly important because it's highly modifiable — B vitamins (B6, B12, and folate) effectively lower homocysteine in most people. Optimal is below 8 μmol/L.

NT-proBNP: The Cardiac Strain Marker

N-terminal pro-B-type natriuretic peptide (NT-proBNP) is released by the heart when it's under strain — either from volume overload, pressure overload, or myocardial damage. Elevated levels (> 125 pg/mL in those under 75) can indicate subclinical heart failure, even in people without symptoms. It's increasingly used as a screening tool in preventive cardiology.

Coronary Artery Calcium (CAC) Score

While not a blood test, the CAC score deserves mention as a complementary assessment. This low-dose CT scan quantifies calcified plaque in the coronary arteries, providing a direct measure of atherosclerotic burden. A CAC score of zero indicates very low 10-year risk, while scores above 100 indicate significant plaque and warrant aggressive risk factor management. It's particularly useful for reclassifying risk in "borderline" patients.

Building Your Cardiovascular Risk Profile

A comprehensive cardiovascular risk assessment should include:

• Standard lipid panel (total cholesterol, LDL-C, HDL-C, triglycerides)
• ApoB (not routinely included — request specifically)
• Lp(a) (one-time test — request if never done)
• hs-CRP
• Homocysteine
• Fasting insulin and glucose (metabolic health impacts cardiovascular risk)
• HbA1c
• Consider CAC score if you're over 40 or have risk factors

The Bottom Line

Heart disease is not an inevitable consequence of ageing — it's the end result of decades of unmanaged risk factors. By testing the right markers early and acting on the results, you can identify and modify your risk profile long before disease develops. The markers listed above go far beyond what a standard lipid panel reveals, and they're available through most Australian pathology providers. Ask for them.

References

1. Sniderman AD, et al. Apolipoprotein B Particles and Cardiovascular Disease. JAMA Cardiol. 2019;4(12):1287-1295. doi:10.1001/jamacardio.2019.3780
2. Ridker PM, et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease (CANTOS). N Engl J Med. 2017;377(12):1119-1131. doi:10.1056/NEJMoa1707914
3. Nordestgaard BG, et al. Lipoprotein(a) as a cardiovascular risk factor. Eur Heart J. 2010;31(23):2844-2853. doi:10.1093/eurheartj/ehq386
4. Australian Institute of Health and Welfare. Heart, stroke and vascular disease: Australian facts. AIHW Cat. No. CVD 92. Canberra: AIHW; 2023.
5. Greenland P, et al. Coronary Artery Calcium Score and Cardiovascular Risk. J Am Coll Cardiol. 2018;72(4):434-447. doi:10.1016/j.jacc.2018.05.027